Figure 1. Screening and counselling regarding post-transplant cancer risk.
| World Journal of Oncology, ISSN 1920-4531 print, 1920-454X online, Open Access |
| Article copyright, the authors; Journal compilation copyright, World J Oncol and Elmer Press Inc |
| Journal website https://www.wjon.org |
Original Article
Volume 15, Number 4, August 2024, pages 592-597
Cancer Screening in Renal Transplant Recipients: Real-World Data
Figure
Tables
| Characteristics | Number | Percentage (%) | P value |
|---|---|---|---|
| Age at diagnosis | |||
| Median (range) | 56.5 (16.9 - 70.2) | ||
| Gender | |||
| Male | 27 | 69.2% | 0.02 |
| Female | 12 | 30.8% | |
| Comorbidities | |||
| No | 7 | 17.9% | < 0.001 |
| Yes | 32 | 82.1% | |
| Dialysis before transplant | |||
| Yes | 23 | 58.9% | 0.2712 |
| No | 16 | 41.1% | |
| Family history for malignancy | |||
| Yes | 18 | 46.2% | 0.6360 |
| No | 21 | 53.8% | |
| Counseling on cancer risk prior to transplant | |||
| Yes | 7 | 17.9% | < 0.001 |
| No | 32 | 82.1% | |
| Initial cancer diagnosis | |||
| Through screening | 3 | 7.7% | < 0.001 |
| Symptoms related to primary disease | 36 | 92.3% | |
| Stage at diagnosis | |||
| Localized | 23 | 58.9% | 0.27 |
| Metastatic | 16 | 41.1% | |
| Status at last follow-up | |||
| Alive | 22 | 56.4% | 0.42 |
| Died | 17 | 43.6% |
| Characteristics | Patients on screening | Patients not on screening |
|---|---|---|
| Number of patients (%) | 3 | 36 |
| Age at diagnosis | ||
| Median (range) | 48.5 (16.9 - 58.3) | 57.1 (18.1 - 70.2) |
| Gender | ||
| Male | 2 | 25 |
| Female | 1 | 11 |
| Comorbidities | ||
| No | 1 | 6 |
| Yes | 2 | 30 |
| Family history for malignancy | ||
| Yes | 1 | 17 |
| No | 2 | 19 |
| Counseling on cancer risk prior to transplant | ||
| Yes | 3 | 4 |
| No | 0 | 32 |
| Stage at diagnosis | ||
| Localized | 3 | 20 |
| Metastatic | 0 | 16 |
| Status at last follow-up | ||
| Alive | 3 | 19 |
| Died | 0 | 17 |